CS logo
small CS logo
Lucille Parker Markey Cancer Center, University of Kentucky

Lexington, Kentucky, United States
Clinic in Lexington, Kentucky
800 Rose St, Lexington, KY 40536

About Lucille Parker Markey Cancer Center, University of Kentucky


The University of Kentucky Markey Cancer Center is an academic, clinical and research center located in Lexington, Kentucky. It was established in 1985, and has grown to 28 departments across eight colleges.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
NSABP Foundation Inc
4
Theradex
2
Alliance for Clinical Trials in Oncology
1
NCIC Clinical Trials Group
1
Prologue Research International
1
SWOG Cancer Research Network
1
Vical
1
Total Rows: 7

Clinical Trials at Lucille Parker Markey Cancer Center, University of Kentucky


During the past decade, Lucille Parker Markey Cancer Center, University of Kentucky conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
1994-08-01
2009-11-01
Completed
810
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
1997-05-01
2006-03-01
Completed
Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
1998-06-01
2002-12-01
Completed
89
Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
1998-07-01
2002-09-01
Completed
S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
2000-02-01
2006-03-01
Completed
240
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
2001-05-01
2010-12-01
Completed
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Lucille Parker Markey Cancer Center, University of Kentucky" #1 sponsor was "NSABP Foundation Inc" with 4 trials, followed by "Theradex" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "NCIC Clinical Trials Group" with 1 trials sponsored and "Prologue Research International" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lucille Parker Markey Cancer Center, University of Kentucky" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNSABP Foundation Inc: 4NSABP Foundation Inc: 4Theradex: 2Theradex: 2Alliance for ClinicalTrials in Oncology: 1Alliance for ClinicalTrials in Oncology: 1NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1Prologue ResearchInternational: 1Prologue ResearchInternational: 1SWOG Cancer ResearchNetwork: 1SWOG Cancer ResearchNetwork: 1Vical: 1Vical: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Cancer Institute (NCI): 6National Cancer Institute (NCI): 6NCIC Clinical Trials Group: 1NCIC Clinical Trials Group: 1

Clinical Trials Conditions at Lucille Parker Markey Cancer Center, University of Kentucky


According to Clinical.Site data, the most researched conditions in "Lucille Parker Markey Cancer Center, University of Kentucky" are "Breast Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Kidney Cancer" (1 trials), "Leukemia" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Lucille Parker Markey Cancer Center, University of Kentucky" in a lesser frequency.

Clinical Trials Intervention Types at Lucille Parker Markey Cancer Center, University of Kentucky


Most popular intervention types in "Lucille Parker Markey Cancer Center, University of Kentucky" are "Drug" (10 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (3 trials), "DHA-paclitaxel" (2 trials), "Adriamycin" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Lucille Parker Markey Cancer Center, University of Kentucky


The vast majority of trials in "Lucille Parker Markey Cancer Center, University of Kentucky" are 5 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Lucille Parker Markey Cancer Center, University of Kentucky


Currently, there are NaN active trials in "Lucille Parker Markey Cancer Center, University of Kentucky". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Lucille Parker Markey Cancer Center, University of Kentucky, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Lucille Parker Markey Cancer Center, University of Kentucky, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 4Phase 2: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Unknown status: 2Unknown status: 2